G. P. Menge

510 total citations
10 papers, 397 citations indexed

About

G. P. Menge is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, G. P. Menge has authored 10 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 5 papers in Psychiatry and Mental health and 3 papers in Pharmacology. Recurrent topics in G. P. Menge's work include Pharmacological Effects and Toxicity Studies (6 papers), Epilepsy research and treatment (5 papers) and Drug Transport and Resistance Mechanisms (2 papers). G. P. Menge is often cited by papers focused on Pharmacological Effects and Toxicity Studies (6 papers), Epilepsy research and treatment (5 papers) and Drug Transport and Resistance Mechanisms (2 papers). G. P. Menge collaborates with scholars based in Switzerland, Finland and Italy. G. P. Menge's co-authors include J.P. Dubois, P Haring, Veijo Saano, Birgit Svenstrup, J. W. Faigle, Tapani Keränen, Klaus-Dieter Stoll, Jukka Jolkkonen, Barbara Tettenborn and Jensen Pk and has published in prestigious journals such as SHILAP Revista de lepidopterología, Epilepsia and Acta Neurologica Scandinavica.

In The Last Decade

G. P. Menge

10 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. P. Menge Switzerland	8	320	316	92	74	44	10	397
A.A. Elyas United Kingdom	12	366 1.1×	375 1.2×	78 0.8×	74 1.0×	18 0.4×	16	449
Philip N. Patsalos United Kingdom	8	435 1.4×	384 1.2×	92 1.0×	191 2.6×	41 0.9×	8	614
T. R. Browne United States	15	384 1.2×	363 1.1×	80 0.9×	188 2.5×	31 0.7×	21	603
E Mesdjian France	13	202 0.6×	260 0.8×	84 0.9×	90 1.2×	63 1.4×	35	462
Dave Berry United Kingdom	8	381 1.2×	388 1.2×	58 0.6×	97 1.3×	13 0.3×	12	603
John H. Tyrer Australia	8	160 0.5×	176 0.6×	42 0.5×	30 0.4×	39 0.9×	15	403
Eadie Mj Australia	11	201 0.6×	222 0.7×	44 0.5×	56 0.8×	25 0.6×	31	328
Jagdev Sidhu Australia	10	159 0.5×	147 0.5×	28 0.3×	50 0.7×	48 1.1×	18	390
Elisabeth Korn‐Merker Germany	12	367 1.1×	342 1.1×	65 0.7×	73 1.0×	9 0.2×	16	461
René Coupez Belgium	10	386 1.2×	377 1.2×	122 1.3×	81 1.1×	37 0.8×	10	566

Countries citing papers authored by G. P. Menge

Since Specialization

Citations

This map shows the geographic impact of G. P. Menge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. P. Menge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. P. Menge more than expected).

Fields of papers citing papers by G. P. Menge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. P. Menge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. P. Menge. The network helps show where G. P. Menge may publish in the future.

Co-authorship network of co-authors of G. P. Menge

This figure shows the co-authorship network connecting the top 25 collaborators of G. P. Menge. A scholar is included among the top collaborators of G. P. Menge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. P. Menge. G. P. Menge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Keränen, Tapani, et al.. (2009). Oxcarbazepine does not interact with cimetidine in healthy volunteers. Acta Neurologica Scandinavica. 85(4). 239–242. 2 indexed citations

Zaccara, Gaetano, et al.. (1993). Influence of Single and Repeated Doses of Oxcarbazepine on the Pharmacokinetic Profile of Felodipine. Therapeutic Drug Monitoring. 15(1). 39–42. 47 indexed citations

Saano, Veijo, et al.. (1992). Possible Interaction Between Oxcarbazepine and an Oral Contraceptive. Epilepsia. 33(6). 1149–1152. 107 indexed citations

Keränen, Tapani, Jukka Jolkkonen, Jensen Pk, G. P. Menge, & Per‐Erik Andersson. (1992). Absence of interaction between oxcarbazepine and erythromycin. Acta Neurologica Scandinavica. 86(2). 120–123. 52 indexed citations

Tettenborn, Barbara, et al.. (1992). Oxcarbazepine Does Not Affect the Anticoagulant Activity of Warfarin. Epilepsia. 33(6). 1145–1148. 55 indexed citations

Faigle, J. W. & G. P. Menge. (1990). Metabolic Characteristics of Oxcarbazepine (^®Trileptal) and their Beneficial Implications for Enzyme Induction and Drug Interactions. Behavioural Neurology. 3(1). 21–30. 33 indexed citations

Menge, G. P., et al.. (1990). Metabolic characteristics of oxcarbazepine (®trileptal) and their beneficial implications for enzyme induction and drug interactions.. SHILAP Revista de lepidopterología. 3(1). 21–30. 32 indexed citations

Menge, G. P., et al.. (1987). Simultaneous determination of carbamazepine, oxcarbazepine and their main metabolites in plasma by liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 414(2). 477–483. 28 indexed citations

Menge, G. P. & J.P. Dubois. (1984). Determination of aminoglutethimide and N-acetylaminoglutethimide in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 310(2). 431–437. 7 indexed citations

10.

Menge, G. P. & J.P. Dubois. (1983). Determination of oxcarbazepine in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 275(1). 189–194. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact